Clinical Trial Update: Methylene Blue for the Prevention of Hypotension During Hemodialysis [Phase 2]

View source ↗

Summary

Clinical Trial Update reports the Phase 2 completion of a study evaluating methylene blue to prevent hypotension during hemodialysis, in patients with acute kid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intradialytic Hypertension
• Intradialytic Hypotension
• Kidney Injury
• Shock

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Acute Kidney Injury, Shock | Phase 2 | Status: COMPLETED